CHA AI Healthkare Amends Convertible Bond Issuance to 5 Billion Won, Private Placement to Related Party Raises Dilution Concerns
CHA AI Healthkare has finalized a revised decision to issue 5.001 billion KRW in 32nd series convertible bonds, reduced from the original 10 billion, with a payment date of June 19, 2026.
The conversion price is 12,463 KRW, 90.9% above the current price of 6,530 KRW; conversion is locked for one year, but a ratchet clause allows adjustment to a minimum of 8,725 KRW if the stock price falls.
The bonds are privately placed to Chacares, the largest investor of the largest shareholder, and the proceeds will be used for investment; more than five amendments indicate delays and financial uncertainty.
Combined with existing 40 billion KRW convertible bonds, total potential conversion shares reach 4.91 million, representing 26.97% of outstanding shares, posing long-term dilution risk.
[AI Summary]CHA AI Healthkare successfully raised 5 billion KRW through a private convertible bond issuance to a related party, but the high conversion price relative to the current stock price delays immediate dilution; however, if the stock price underperforms, downward adjustment of the conversion price could lead to dilution. Frequent amendments and delays reflect financing difficulties, and the total 27% potential dilution overhang negatively impacts shareholder value.
KOSPI Filing Information
[Correction of Description] Report on Major Matters (Decision on Issuance of Convertible Bonds)